TWA
JAZZ icon

TCI Wealth Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

TCI Wealth Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-36
Closed -$5.27K – 1226
2023
Q1 		$5.27K Sell
36
-59
-62% -$8.73K ﹤0.01% 1491
2022
Q4 		$15.1K Buy
95
+59
+164% +$8.65K ﹤0.01% 829
2022
Q3 		$5K Sell
36
-1
-3% -$152 ﹤0.01% 1471
2022
Q2 		$6K Hold
37
– – ﹤0.01% 1358
2022
Q1 		$6K Hold
37
– – ﹤0.01% 1427
2021
Q4 		$5K Hold
37
– – ﹤0.01% 1669
2021
Q3 		$5K Sell
37
-32
-46% -$4.83K ﹤0.01% 1605
2021
Q2 		$12K Buy
69
+26
+60% +$4.5K ﹤0.01% 854
2021
Q1 		$7K Hold
43
– – ﹤0.01% 1059
2020
Q4 		$7K Hold
43
– – ﹤0.01% 751
2020
Q3 		$6K Hold
43
– – ﹤0.01% 715
2020
Q2 		$5K Buy
43
+12
+39% +$1.33K ﹤0.01% 746
2020
Q1 		$3K Buy
+31
New +$4.01K ﹤0.01% 881
2018
Q4 		– Sell
-3
Closed -$1K – 1536
2018
Q3 		$1K Sell
3
-7
-70% -$1.2K ﹤0.01% 1250
2018
Q2 		$2K Buy
+10
New +$1.64K ﹤0.01% 1091
2017
Q3 		– Sell
-50
Closed -$8K – 1351
2017
Q2 		$8K Buy
+50
New +$7.65K ﹤0.01% 638
2016
Q4 		– Sell
-12
Closed -$1K – 1411
2016
Q3 		$1K Buy
+12
New +$1.62K ﹤0.01% 1146

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
SC
Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

TCI Wealth Advisors's JAZZ Position: Q2 2023 in Review

TCI Wealth Advisors sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2023, closing a stake of 36 shares — an estimated $5.27K sold.

TCI Wealth Advisors first reported a position in JAZZ in Q3 2016 and held it in 17 quarters. The position peaked at $15.1K in Q4 2022. 471 funds tracked by Wall St. Rank hold JAZZ as of Q2 2023.

  • TCI Wealth Advisors reported no remaining Jazz Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • TCI Wealth Advisors sold 36 Jazz Pharmaceuticals shares in Q2 2023, an estimated $5.27K.
  • TCI Wealth Advisors first reported a position in Jazz Pharmaceuticals in Q3 2016 and held it in 17 quarters.
  • TCI Wealth Advisors's Jazz Pharmaceuticals position peaked at $15.1K in Q4 2022.
  • 471 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.